carbidopa has been researched along with Carcinoma, Hepatocellular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frakolaki, E; Gkogkosi, P; Paspaltsis, I; Siaterli, MZ; Sklaviadis, T; Vassilacopoulou, D; Vassilaki, N; Vassiliou, AG | 1 |
1 other study(ies) available for carbidopa and Carcinoma, Hepatocellular
Article | Year |
---|---|
L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Carcinoma, Hepatocellular; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neuroblastoma; Peptide Fragments; Peptide Library; Phosphatidylinositol 3-Kinases; Tumor Cells, Cultured | 2019 |